A study to find out how healthy people tolerate a new drug called S221237.
This research is looking at a new drug called S221237. For the first time, we're giving it to healthy volunteers to carefully observe how their bodies handle it. We want to learn if it's safe and what effects it might have. This type of study, called a Phase 1 trial, is a crucial early step. It helps us understand the drug better before it's tested in people who have specific health conditions. Even though this drug might eventually be used for Parkinson's disease, this particular study is focused on healthy individuals to gather essential safety information.
At a glance
What is this study about?
This study is about a new medicine called S221237. Researchers are giving this new drug to healthy people for the very first time. The main goal is to see how the healthy body reacts to the drug, how much of it stays in the body, and how the body gets rid of it. This helps doctors work out a safe dose, and check for any side effects.
This kind of study is called a 'Phase 1' trial, and it's the earliest stage of testing a new drug in humans. It's really important because it tells us if the drug is safe enough to be tested further. Think of it like taking the first few steps with a new invention – you want to make sure it works properly and safely before you try to use it for bigger tasks.
The drug S221237 is being developed with the hope that it might one day help people with Parkinson's disease. However, this specific study isn't about treating Parkinson's. Instead, it's about making sure the drug is safe and well-tolerated in healthy individuals first. The information gathered here will be vital for future studies that might involve people living with Parkinson's.
Key takeaways
- This is an early study testing a new drug for safety in healthy people.
- The drug, S221237, is being developed for Parkinson's disease, but this specific study is not a treatment.
- Participants will be closely monitored for how their body reacts to the drug.
- You must be at least 18 years old and in good health to be considered.
- Participation involves clinic visits, assessments, and taking the study drug.
- You can stop taking part at any time without affecting your medical care.
Who may be eligible?
This study is looking for healthy volunteers who are at least 18 years old. Both men and women can take part. There's no upper age limit, but you'll need to be in good general health.
To make sure this study is safe for everyone involved, you'll have a health check to confirm you meet all the requirements. This check will look at your medical history and current health to ensure the study is right for you. Unfortunately, if you have certain health conditions or are taking specific medications, you might not be able to join.
The research team will review your health information in detail. They are the best people to tell you for certain if you can take part in this particular study, so it's always best to discuss it with them.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Am I at least 18 years old?
- Am I generally healthy and do not have any major ongoing health conditions?
- Am I currently taking any regular medications (other than perhaps a multivitamin)?
- Am I able to attend all required clinic visits?
- Do I understand that this study is not for treating Parkinson's disease?
- Am I willing to follow specific study instructions?
What does participation involve?
If you decide to take part, you'll first have a full health check to make sure you're suitable. Once accepted, you'll receive the study drug, S221237, likely as a tablet or injection, and will be carefully monitored by the medical team. This will involve regular visits to the clinic, which might include blood tests, checking your heart and breathing, and answering questions about how you feel.
The study will involve several visits over a specific period, perhaps a few weeks or months, during which you’ll be asked to follow certain rules, such as not taking other medications or avoiding certain foods. The research team will explain everything to you clearly. You'll have follow-up appointments to make sure you're well after the drug has left your system. You can ask for a detailed schedule of visits and assessments before agreeing to participate.
Potential risks and benefits
Locations (1)
- —UnverifiedFrance
Common questions
What is a 'Phase 1' study?
It's the very first time a new drug is given to humans, usually healthy volunteers. The main aim is to check if it's safe and how the body handles it.
Will this drug help me if I have Parkinson's disease?
No, this study is for healthy volunteers to test safety, not to treat Parkinson's. Future studies will test if it helps people with the condition.
What if I get side effects?
The medical team will closely monitor you for any side effects. If you experience any, you should tell them immediately. They are there to help you and ensure your safety.
Do I have to take part?
No, it's completely your choice. You'll be given all the information and time to decide, and you can withdraw at any point without it affecting your usual healthcare.
Will I be paid for participating?
Sometimes, studies offer a payment for your time and travel costs. You should ask the study team if this is the case for this particular study.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.